MusclePharm Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. MusclePharm last-minute Real Value cannot be determined due to lack of data. The latest price of MusclePharm is USD0.0. Our model forecasts the value of MusclePharm from analyzing the firm fundamentals such as Total Asset of 11.21 M, net income of (12.87 M), and Revenue of 50.04 M as well as examining its technical indicators and probability of bankruptcy.
MusclePharm Total Value Analysis
MusclePharm is now projected to have takeover price of 0 with market capitalization of 0, debt of 10.71 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MusclePharm fundamentals before making investing decisions based on enterprise value of the companyMusclePharm Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of MusclePharm connotes not a very effective usage of assets in January.MusclePharm Profitability Analysis
The company reported the revenue of 50.04 M. Net Loss for the year was (12.87 M) with profit before overhead, payroll, taxes, and interest of 0.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in MusclePharm Pink Sheet
If you are still planning to invest in MusclePharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MusclePharm's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |